Good Fellow Healthcare Holdings Limited provides group earnings guidance for the nine months ended 31 December 2022. The Group expects to record a loss of approximately HKD 10.5 million for the Current Period, as compared to a profit of approximately HKD 6.9 million for the nine months ended 31 December 2021 (the "Corresponding Period"). The expected turnaround from profit to loss is primarily attributable to the one-off gain in disposal of subsidiaries of approximately HKD 31.7 million during the Corresponding Period.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.137 HKD | 0.00% | +19.13% | -45.20% |
1st Jan change | Capi. | |
---|---|---|
-45.20% | 9.41M | |
-19.34% | 16.51B | |
+5.41% | 12.53B | |
+4.64% | 11.74B | |
+2.21% | 10.06B | |
+29.17% | 8.71B | |
-2.39% | 7.57B | |
+18.60% | 7.14B | |
+4.93% | 6.68B | |
+44.78% | 4.54B |
- Stock Market
- Equities
- 8143 Stock
- News Good Fellow Healthcare Holdings Limited
- Good Fellow Healthcare Holdings Limited Provides Group Earnings Guidance for the Nine Months Ended 31 December 2022